BioXell (SIX:COPN)

Company Profile

BioXell is a biopharmaceutical company focused on the discovery and development of drugs that exploit novel mechanisms of action to treat important urological, inflammatory, and related disorders with significant unmet medical needs. The Company was founded in 2002 as a spin-out from Roche.

Company Info

  • HQ: Milan, Italy
Index Team:
Website:
bioxell.com
Sector:
Healthcare
Status:
Exited